Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
Gefen Capital
Herzliya PituachSeed–Series B
8 people
TVM Capital
MunichSeed–Late Stage$1.1M – $16.2M
10 people
Texas Ventures
HoustonSeed–Late Stage
6 people
PM Equity Partner
LausanneSeries A–Growth$2M – $50M
11 people
Launch Tennessee
NashvillePre-Seed–Series B
1 person
2050 Capital
LondonSeed–Series C$200K – $3M
7 people
Ennovation Ventures
NanjingSeed–Series B
13 people
Innvotec Ltd.
LondonSeries A–Series B$317.5K – $635K
4 people
Amzak Health
New YorkSeed–Growth
5 people
Sound Bioventures
MalmöSeed–Growth
9 people
Volcanics Venture
ShanghaiSeed–Series B
8 people
Daft Capital
Palo AltoPre-Seed–Series B$500K – $2M
1 person
JStar Capital Investments
AustinSeed–Series C
13 people
AbCellera
VancouverSeries B–Late Stage
26 people
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
6 people
Black Diamond Ventures
GlendalePre-Seed–Growth$2M – $10M
8 people
Kama Flow
MoscowSeed–Growth
4 people
Truffle Capital
ParisSeed–Growth$5M – $15M
7 people
Global Health Investment Corporation
New YorkSeed–Series B
5 people
IPD Capital
AventuraSeed–Series B
8 people
Mitsubishi UFJ Capital
TokyoPre-Seed–Growth
5 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
11 people
Amgen Ventures
Thousand OaksSeed–Late Stage$1M – $3M
2 people
Ameba Capital
ShanghaiSeed–Growth
10 people
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.













































































